Gloria M. Mccarthy - Mar 1, 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & Chief Administrative Off
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol: ELV
Transactions as of: Mar 1, 2023
Transactions value $: -$2,834,867
Form type: 4
Date filed: 3/3/2023, 03:22 PM
Previous filing: Mar 3, 2022
Next filing: Mar 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	-$289K	-617	-1.02%	$469.03	60.1K	Mar 1, 2023	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2.13K	+3.55%	$0.00	62.2K	Mar 1, 2023	Direct	F2
transaction	ELV	Common Stock	Award	$0	+9.72K	+15.61%	$0.00	72K	Mar 1, 2023	Direct	F3
transaction	ELV	Common Stock	Tax liability	-$2.55M	-5.43K	-7.55%	$468.78	66.5K	Mar 2, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+8.2K		$0.00	8.2K	Mar 1, 2023	Common Stock	8.2K	$469.03	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 711 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
F3	Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4	The option represents a right to purchase a total of 8,195 shares, and is exercisable in one installment of 2,731 and two installments of 2,732 shares each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.